ADAM THABET: Open Payments
NPI 1427351394 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$661 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $661
Food & beverage: $661
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 5 | $239 |
| Novo Nordisk Inc | 7 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $56 |
| ABBVIE INC. | 3 | $53 |
| Exact Sciences Corporation | 2 | $31 |
| Echosens North America, Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $16 |
Products named: REZDIFFRA, Rybelsus, CAPLYTA, DALVANCE, Cologuard Collection Kit, Fibroscan, REXULTI, TRELEGY ELLIPTA.
Industry payments across NY — which companies pay providers there.
